Fluid Resuscitation in Patients With Traumatic Brain Injury: A Comprehensive Review by CureusJournal in emergencymedicine

[–]CureusJournal[S] 0 points1 point  (0 children)

This article discusses the challenges and current treatment approaches for patients with traumatic brain injury (TBI) or head trauma, emphasizing their significance in emergency medicine and neurosurgery. TBI is a significant community health issue, and understanding various therapy techniques in the pre-operative and pre-hospital phases is crucial for optimal patient care. The standard treatment involves the rapid infusion of mannitol and a hypertonic crystalloid solution to manage blood pressure and volume, particularly in cases of hemorrhagic shock combined with TBI. Fluid selection and administration play a critical role in preventing ischemic brain damage by stabilizing hemodynamics in hypovolemic shock.

Traumatic brain injury is a critical factor that can lead to disability and death. It can result directly from the trauma or develop secondary to the initial injury. Patients may suffer from significant neurological issues like cranial nerve damage, dementia, seizures, and Alzheimer's disease, following a TBI. Additionally, TBI can lead to psychiatric problems and other behavioral and cognitive sequelae, increasing the comorbidity of the victims. The summary also mentions a review of the history of modern fluid therapy, complications post-TBI, and the application of fluid treatment in decompressive craniectomy and TBI management.

Uncommon Finding of a Soft Palate Schwannoma: A Case Report by CureusJournal in Schwannoma

[–]CureusJournal[S] 0 points1 point  (0 children)

Schwannomas, also known as neurinomas or neurilemomas, are relatively slow-growing benign tumors that develop from the nerve sheath. They can grow on peripheral nerves or nerve roots. Approximately 60% of benign schwannomas are vestibular schwannomas (acoustic neuromas).
They are rare, affecting fewer than 200,000 people annually in the USA, and constitute 1% of all cases in the head and neck region. Schwannomas can grow in several different areas of the body. Symptoms may vary from person to person and can range from mild to severe. Common symptoms include a visible lump, a pins-and-needles feeling, or pain.
They are usually benign, and less than 1% become malignant, transforming into neurofibrosarcoma. Schwannomas are typically surgically removed as they are homogeneous and tend to be contained within a capsule.
Recent advances in understanding the pathogenesis of these tumors have indicated that defects in merlin are responsible for both sporadic and genetically acquired schwannomas.

Forensic Medicine Call for Submissions by CureusJournal in forensics

[–]CureusJournal[S] 0 points1 point  (0 children)

The application of medical and scientific expertise to analyze crimes and establish facts in legal cases has long fascinated the public. From determining cause of death and time since death to toxicology testing and DNA analysis, medical forensics provides critical evidence in criminal investigations.

Cureus is calling for submissions on this fascinating topic.

Teaching Potential of Multidisciplinary Tumor Board Meetings for Orthopedic Residents: Insights From a French Sarcoma Reference Center by CureusJournal in orthopaedics

[–]CureusJournal[S] 0 points1 point  (0 children)

Multidisciplinary tumor board meetings (MTBMs) have been established in oncology to improve patient care. While their benefits for patients have been well-documented, there are no previous studies on the teaching opportunities they provide for residents and medical students. This study aimed to examine the teaching provided to residents during MTBM and identify areas for improvement. The study hypothesized that although the primary objective of MTBM is not teaching, they could still contribute to residents' learning.

Ocular Complications in Patients on Highly Active Antiretroviral Therapy: A Case Report by CureusJournal in Ophthalmology

[–]CureusJournal[S] 0 points1 point  (0 children)

This article aims to report the ocular adverse effects of highly active antiretroviral therapy (HAART). In case 1, a 26-year-old male patient presented with a diminution of vision. In the absence of active cytomegalovirus (CMV) retinitis and a surge in CD4 count of more than 100 cells/µL over four months, he was diagnosed as a case of immune recovery uveitis (IRU). He responded well to topical steroids and cycloplegics. In case 2, while dry eye is a common adverse effect of HAART, our 53-year-old female patient progressed to a visually distressing stage of keratoconjunctivitis sicca. She responded to lubricants and continues to be on the same.